S. Richman

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

P. Quirke, J. Cheadle, G. Middleton, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

What can the molecular pathologist offer for optimal decision making?

P. Quirke, S. Richman, G. Hutchins, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

KRAS and BRAF mutations in Nigerian colorectal cancers.

H. Grabsch, P. Quirke, F. Abdulkareem, 2012, West African journal of medicine.